Andlauer Healthcare Group (TSE:AND)
TSX:AND
Holding TSE:AND?
Track your performance easily

Andlauer Healthcare Group (AND) Financial Statements

61 Followers

Andlauer Healthcare Group Financial Overview

Andlauer Healthcare Group's market cap is currently ―. The company's EPS TTM is C$1.604; its P/E ratio is 27.06; and it has a dividend yield of 0.94%. Andlauer Healthcare Group is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is C$0.47. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total RevenueC$ 159.60MC$ 161.45MC$ 161.14MC$ 169.07MC$ 156.75M
Gross ProfitC$ 54.60MC$ 54.02MC$ 52.40MC$ 40.87MC$ 34.53M
EBITC$ 24.44MC$ 23.18MC$ 21.95MC$ 28.22MC$ 22.81M
EBITDAC$ 41.87MC$ 40.83MC$ 40.32MC$ 45.60MC$ 40.12M
Net Income Common StockholdersC$ 16.29MC$ 15.73MC$ 14.92MC$ 18.56MC$ 15.34M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 35.99MC$ 40.73MC$ 68.16MC$ 59.74MC$ 68.28M
Total AssetsC$ 649.92MC$ 657.78MC$ 687.17MC$ 682.43MC$ 698.08M
Total DebtC$ 158.97MC$ 169.12MC$ 100.25MC$ 127.90MC$ 129.52M
Net DebtC$ 122.98MC$ 128.39MC$ 32.10MC$ 68.16MC$ 61.24M
Total LiabilitiesC$ 245.50MC$ 253.79MC$ 207.15MC$ 212.86MC$ 224.16M
Stockholders EquityC$ 404.42MC$ 404.00MC$ 480.02MC$ 469.57MC$ 473.92M
Cash Flow-
Free Cash FlowC$ 26.21MC$ 36.52MC$ 25.17MC$ 17.22MC$ 23.19M
Operating Cash FlowC$ 30.66MC$ 37.92MC$ 33.20MC$ 25.16MC$ 28.63M
Investing Cash FlowC$ -4.45MC$ -1.39MC$ -8.03MC$ -7.94MC$ -5.45M
Financing Cash FlowC$ -30.79MC$ -64.06MC$ -17.41MC$ -25.26MC$ -39.66M
Currency in CAD

Andlauer Healthcare Group Earnings and Revenue History

Andlauer Healthcare Group Debt to Assets

Andlauer Healthcare Group Cash Flow

Andlauer Healthcare Group Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis